Head-to-head · WeighScore
Cost Plus Drugs vs OlleveCare
The verdict
Cost Plus Drugs takes it — 58.5/100 to 46.2/100.
Cost Plus Drugs grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Mark Cuban's transparent-pricing online pharmacy.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Cost Plus Drugs | OlleveCare |
|---|---|---|
| WeighScore | 58.5/100 | 46.2/100 |
| Grade | C | C |
| Scorecard rank | #371 | #497 |
| Semaglutide | $279/mo (brand Ozempic) | Not disclosed |
| Tirzepatide | Not disclosed | Not disclosed |
| Coverage | All 50 states | 13 states |
| Brand-name access | Yes | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #371 · C
Strengths
- Transparent pricing: wholesale cost + 15% markup + $5 pharmacy fee, the same for everyone
- Around $279/mo for branded Ozempic — well below typical retail list prices
- Mark Cuban's PBM-disrupting pharmacy, praised by Forbes Health, Wired, and KFF Health News
- Ships to all 50 states; genuine FDA-approved Novo Nordisk Ozempic, not compounded
- Partnered with 9amHealth so you can get prescribed and fill at Cost Plus pricing
Where it loses points
- Fulfillment only — no telehealth intake; you need a prescription from an outside clinician
- Ozempic is FDA-indicated for type 2 diabetes, not weight management — weight-loss use is off-label
- Wegovy availability has been spotty — check current stock before assuming it ships
- No compounded semaglutide or tirzepatide — brand only
- No clinical follow-up — side-effect monitoring falls to your prescribing clinician
Graded #497 · C
Strengths
- 13 states listed explicitly (VA, FL, AZ, MA, HI, IA, MD, NM, WA, KS, NY, DC, ID)
- Both semaglutide and tirzepatide offered — switch molecules without switching platforms
- Multi-service platform — GLP-1, virtual urgent care, and non-controlled refills with one provider
- Cash-pay with a superbill option for out-of-network reimbursement
- Founder Ahmed Emam is named in the footer
Where it loses points
- Legal entity name not disclosed anywhere — can't be verified in a state registry
- Pricing not shown before booking — you must enter the intake flow to see the fee
- Pharmacy partner not named; model appears to fill at your preferred retail pharmacy
- No medical director or prescribing clinician named — only 'board-certified providers'
- No LegitScript badge, BBB profile, or HIPAA/SOC 2 seals displayed
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.